Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

Clinical trial NCT01042977 · COMPLETED

Trial details

NCT number: NCT01042977
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Cardiovascular Disease Inadequate Glycaemic Control

Start date: 2010-03-01
Primary completion: 2011-05-01
Enrollment: 964

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.